573675-31-7

Basic information

• Product Name: 7-bromo-4-chloropyrido[3,2-d]pyrimidine
• Synonyms: 7-bromo-4-chloropyrido[3,2-d]pyrimidine;7-Bromo-4-chloro-pyrido[3...
• CAS NO: 573675-31-7
• Molecular Formula: C₇H₃BrClN₃
• Molecular Weight: 244.48
• Product Categories: CHIRAL CHEMICALS
• Mol File: 573675-31-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 334 °C at 760 mmHg
• Flash Point: 155.8 °C
• Appearance: /
• Density: 1.861 g/cm³
• Refractive Index: 1.703
• PKA: -1.91±0.30(Predicted)
• CAS DataBase Reference: 7-bromo-4-chloropyrido[3,2-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-bromo-4-chloropyrido[3,2-d]pyrimidine(573675-31-7)
• EPA Substance Registry System: 7-bromo-4-chloropyrido[3,2-d]pyrimidine(573675-31-7)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• RIDADR: UN 2811 6.1 / PGIII
• HazardClass: IRRITANT
• Hazardous Substances Data: 573675-31-7(Hazardous Substances Data)

Usage

General Description

7-bromo-4-chloropyrido[3,2-d]pyrimidine is a chemical compound with a molecular formula C6H3BrClN4. It is a pyrido[3,2-d]pyrimidine derivative and is a white to off-white crystalline powder. 7-bromo-4-chloropyrido[3,2-d]pyrimidine is used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has the potential to be used in the development of new drugs and has applications in the field of medicinal chemistry. 7-bromo-4-chloropyrido[3,2-d]pyrimidine may also have uses in research and development in the chemical and pharmaceutical industries.

InChI:InChI=1/C7H3BrClN3/c8-4-1-5-6(10-2-4)7(9)12-3-11-5/h1-3H

Upstream product

• 669066-89-1 3-amino-5-bromopyridine-2-carboxylic acid amide 
• 573675-25-9 5-bromo-3-nitropyridine-2-carbonitrile 
• 573675-29-3 7-bromopyrido[3,2-d]pyrimidin-4-ol 

Relevant articles and documents

ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT

The present invention concerns a compound of following general formula (I): where: either R is an R1 group and R′ is an -A1-Cy1 group, or R is an -A1-Cy1 group and R′ is an R1 group, R1 particularly being H or (C1-C6)alkyl group;A1 being an —NH— radical or —NH—CH2— radical;Cy1 particularly being a phenyl group,A is a fused (hetero)aromatic ring having 5 to 7 atoms, for use for treating cancer.

CAPSAICIN RECEPTOR AGONISTS

Capsaicin receptor agonists are provided. Such compounds are ligands that may be used to modulate VRl activity in vivo or in vitro, and are particularly useful in the treatment of conditions responsive to capsaicin receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.